Health Canada - Note to editors

OTTAWA, July 31, 2014 /CNW/ - Health Canada today released the July 2014 issue of the Canadian Adverse Reaction Newsletter (CARN).

This issue includes an article on the anti-cancer drug cisplatin and the risk of blockage of the aorta, the body's main artery.

It also includes an article on hydroxychloroquine, a drug used for rheumatoid arthritis, lupus, and malaria, and the risk of developing low blood sugar; and a case presentation on a suspected interaction between efavirenz, an HIV drug, and ginkgo biloba, a natural health product.

The edition also contains a quarterly summary of health professional and consumer advisories.

The July 2014 edition of CARN is available on Health Canada's website at:

SOURCE Health Canada

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.